Reconstitution of Intestinal CD4 and Th17 T Cells in Antiretroviral Therapy Suppressed HIV-Infected Subjects: Implication for Residual Immune Activation from the Results of a Clinical TrialGabriella d’Ettorre, Vincenzo Vullo, Alessandra Mallano et al.|PLoS ONE|2014Cited by 33
Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjectsGabriella d’Ettorre, Vincenzo Vullo, Marco Francone et al.|Journal of Infection|2011Cited by 25
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative ColitisZuleika Michelini, Lucia Palmisano, Silvia Baroncelli et al.|HIV Clinical Trials|2016Cited by 12
Rate and Determinants of Residual Viremia in Multidrug-Experienced Patients Successfully Treated with Raltegravir-Based RegimensSilvia Baroncelli, Marco Floridia, Maria Franca Pirillo et al.|AIDS Research and Human Retroviruses|2014Cited by 10
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsRaffaella Bucciardini, Marco Floridia, Gabriella d’Ettorre et al.|International Journal of STD & AIDS|2012Cited by 10